Instability of (CTG)•(CAG) microsatellite trinucleotide repeat (TNR) sequences is responsible for more than one dozen neurological or neuromuscular diseases. TNR instability during DNA synthesis is thought to involve slipped strand or hairpin structures in template or nascent DNA strands, although direct evidence for hairpin formation in human cells is lacking. We have used targeted recombination to create a series of isogenic HeLa cell lines in which (CTG)•(CAG) repeats are replicated from an ectopic copy of the c-myc replication origin. In this system the tendency of chromosomal (CTG)•(CAG) tracts to expand or contract was affected by origin location and the leading or lagging strand replication orientation of the repeats, and instability was enhanced by prolonged cell culture, increasing TNR length, and replication inhibition. Hairpin cleavage by synthetic zinc finger nucleases in these cells has provided the first direct evidence for the formation of hairpin structures during replication in vivo.
Expansion of (CTG)•(CAG) trinucleotide repeat microsatellite sequences is responsible for several neuromuscular and neurodegenerative diseases including Huntington’s disease (HD) and myotonic dystrophy type 1 (DM1). In DM1 patients instability of the (CTG)•(CAG) repeats at the DMPK locus is evident during germ cell development and in somatic cells
The tendency of (CTG)•(CAG) repeats to promote DNA instability correlates directly with their stabilities of hairpin formation
TNR hairpin formation in bacteria preferentially leads to contraction of direct repeat sequences in the lagging strand template and expansion of repeated sequences in the leading strand nascent DNA
Several models have been developed to explain how a lagging strand (CTG) hairpin might contribute to TNR contraction
These cell lines revealed that the instability of (CTG)•(CAG) repeats is dependent on the length of the repeat, the age of the cell line, the replication polarity of the TNR, and the activity of the proximal replication origin. Instability was markedly enhanced by inhibition of replication with emetine, Fen1 siRNA or aphidicolin. The pattern of instability showed significant similarities and differences after each of these treatments. To test directly whether the (CTG)•(CAG) TNR could form hairpins in vivo, synthetic zinc finger nucleases were designed which specifically targeted these structures. Expression of these nucleases in the Flp targeted cell lines demonstrated that both leading and lagging strand DNAs form replication-dependent hairpin structures.
Hairpin formation in the template or nascent strands during replication can generate genomic instability by contraction or expansion, respectively, of the number of microsatellite sequence repeats (
Approximately 25 population doublings after clonal selection, PCR amplification with primers flanking the repeat tracts detected no instability at the (CTG)102•(CAG)102 TNR (
The (CTG)102 cells displayed predominantly contractions, while the (CAG)102 cells displayed both expansions and contractions (
Treatment of DM1 patient cells in culture with the replication inhibitors emetine or aphidicolin increased (CTG)•(CAG) instability at the DMPK locus
Aphidicolin inhibits both leading and lagging strand DNA polymerases, whereas emetine preferentially inhibits Okazaki fragment synthesis
The effects of emetine on TNR stability are apparently not due to downregulation of Fen1 nuclease (
The patterns of instability induced by these replication inhibitors are consistent with the predicted stability of (CTG) hairpins vs. (CAG) hairpins
We designed zinc finger nucleases (ZFNs) that could be expressed in human cells to test directly for replication-dependent formation of hairpins in vivo. The engineered ZFNs contain the sequence nonspecific Fok 1 restriction endonuclease catalytic cleavage domain (Fok 1CD) fused to three tandem zinc finger protein domains that each recognize the (GCT) (ZFGCT zinc finger) or (AGC) (ZFAGC zinc finger) trinucleotides to produce, respectively, nucleases that target (CTG) hairpins (termed ZFNCTG), or (CAG) hairpins (termed ZFNCAG). Like Fok 1, ZFNs dimerize through their Fok 1 cleavage domains only when bound to DNA, and this dimerization is necessary for catalytic activity
Previous in vitro characterization of binding by individual zinc finger domains indicates that certain (GCT) zinc fingers may recognize (GCA) triplets and that some (GCA) zinc fingers may recognize (GCT) triplets
The resistance of a significant fraction of the template to digestion by the individual nucleases argued that the ZFNs were specific and that the extracts did not display nonspecific nuclease activity. To confirm this, extracts were prepared from HeLa cells expressing the same zinc finger proteins (ZFPs) omitting the Fok I nuclease domain. We observed that the ZFP containing extracts did not digest the (CTG)102•(CAG)102 DNA substrate (
ZFNCTG or ZFNCAG were expressed in (CTG)102 or (CAG)102 cells and genomic DNA was isolated for spPCR amplification 48 hours later. As shown in
It is formally possible that the decrease in TNR repeat length following ZFN expression is due to ZFN binding to (CTG)•(CAG) hairpins that subsequently induces cleavage by cellular nucleases. We addressed this question further by expressing the zinc finger proteins ZFPCTG and ZFPCAG in (CTG)102 or (CAG)102 cells. Omission of the Fok I nuclease domain in ZFPs resulted in significantly decreased frequencies of TNR contraction (compare
The progenitor (CTG)102•(CAG)102 band was preserved when cells expressed either ZFN individually, while the (CTG)102•(CAG)102 band was completely digested when either (CTG)102 or (CAG)102 cells were co-transfected with a mixture of ZFNCTG and ZFNCAG expression plasmids (
The resistance of the (CTG)102•(CAG)102 band to digestion by a single ZFN supports the view that the ZFNs selectively target hairpin structures. To test whether the sensitivity of the (CTG)102•(CAG)102 TNR to ZFN digestion is dependent on cell division, ZFNCTG or ZFNCAG was expressed in (CTG)102 or (CAG)102 cells during serum starvation. Digestion by ZFNCTG or ZFNCAG was markedly reduced in serum deprived cells, whereas expression of the heteromeric pair of ZFNs eliminated the (CTG)102•(CAG)102 TNR band almost completely, and generated expansion products upon spPCR (
(CTG)12•(CAG)12 cells did not show time-dependent instability, and did not show induction of instability when treated with aphidicolin, emetine, or Fen1 siRNA (
The site-specific integration of specific repeat length (CTG)•(CAG) tracts alongside an ectopic copy of the human c-myc replication origin has allowed analysis of the effect of repeat length, replication polarity and origin location on TNR instability. The clonal origin of each of the cell lines used in this work eliminated progenitor cell heterogeneity and differences in patient age, tissue type, genetic background, and chromosomal location that may have complicated the interpretation of previous studies. In this model we observed that (CTG)•(CAG) microsatellite instability is enhanced by prolonged cell growth, increased repeat length, origin proximity, and the inhibition of replication. Furthermore, the pattern of instability was orientation dependent. When (CTG)102 comprised the lagging template strand, the repeat showed a strong bias towards contraction in vivo, whereas both contractions and expansions were observed when (CAG)102 was present in the lagging strand template.
In bacteria and yeast (CTG)•(CAG) repeat contractions occur more often when the (CTG) sequence, which exhibits greater structure-forming potential
Slowing of leading and lagging strand synthesis with aphidicolin accelerated the (CTG)102 TNR contraction and (CAG)102 TNR expansion in a manner similar to that seen after long term culture. Emetine inhibition of lagging strand DNA synthesis in (CTG)102 cells also resulted in the appearance of a small number of prominent contraction products, as did inhibition of Okazaki fragment maturation by Fen1 knockdown. Each of these inhibitors can also cause fork stalling and reversal
Yang et al. have reported that aphidicolin or emetine treatment of primary fibroblasts from a fetus with DM1 strongly enhanced expansion of the (CTG)216 allele but did not affect the normal (CTG)12 allele
Replication based models posit that expansion occurs because of hairpin formation in lagging strand Okazaki fragments, or in leading strand nascent DNA during fork reversal
Arguing against a major a role for Okazaki fragment maturation in (CTG)•(CAG) expansion, the most dramatic increases in expansions occurred when Okazaki fragment synthesis was inhibited by emetine, which induced two major expanded products in (CAG)102 cells and a complex array of expansion products in (CTG)102 cells. Under these conditions an extended single strand lagging template may potentiate fork reversal and hairpin formation in the displaced leading strand nascent DNA
In the ectopic c-myc origin system, removal of the DUE eliminates origin activity
HD or DM1 (CTG)•(CAG) microsatellites in humans and transgenic mice show varying degrees of expansion bias
Extended passage (CTG)102 cells accumulate primarily contractions in the (CTG)•(CAG) TNR. The replication-dependent sensitivity of the (CTG)•(CAG) TNR to cleavage by either ZFNCTG or ZFNCAG in short term passage (CTG)102 cells implies that both the leading and lagging template strands can form hairpins during unperturbed replication
Shishkin et al. have recently proposed a template switching mechanism for (GAA)•(TTC) expansion that predicts nascent strand hairpin formation as a consequence of leading strand polymerase copying of Okazaki fragments
In the yeast model of large (GAA)•(TTC) expansion, instability is not dependent on fork stalling
(CTG)•(CAG) trinucleotide repeats were amplified from genomic DNA or plasmid clones by PCR and inserted into the Not I restriction site at the 3’ edge of the c-myc replicator plasmids pFRT.myc or pFRT.myc. ΔDUE
HeLa/406 acceptor cells containing a single chromosomal Flp recombinase target were constructed, grown, and transfected as described
The single zinc finger plasmids pc3XB-ZF72, pcXB-ZF83, and a mammalian expression vector, pST1374, were purchased from Addgene Inc. (Cambridge, MA). Proteins with three zinc fingers (ZFPs) were assembled using standard molecular cloning methods. ZFPCTG, containing three ZF72 zinc fingers (Addgene plasmid 13206), and ZFPCAG, containing three ZF83 zinc fingers (Addgene plasmid 13217), were designed with Zinc Finger Targeter (ZiFiT) Version 2.0
For in vitro digestion, ZFP and ZFN proteins were expressed in HeLa cells and immunoprecipitated using EZview Red Anti-FLAG M2 affinity gel (Sigma). ZFN and ZFP proteins were expressed from the same vectors at similar levels (
Standard PCR used 40 ng genomic DNA per reaction. Amplification conditions were 94 °C (5’); 35 cycles of 94 °C (30”), 55 °C (30”), 72 °C (2’); and 72 °C (7’). spPCR used 130 pg genomic DNA per reaction. Amplification conditions were 94 °C (5’); 35 cycles of 94 °C (30”), 55 °C (30”), 72 °C (30”); and 72 °C (7’). Under the short extension conditions of spPCR, the expanded templates seen by standard PCR of (CTG)102 and (CAG)102 genomic DNA were not detected. PCR products were resolved in 7.5% polyacrylamide gels. Images were obtained on a Fuji LAS-3000 using ImageReader and Adobe Photoshop software.
Cells were trypsinized, washed in PBS and fixed overnight at −20 °C in 70% ethanol. Cells were resuspended in PBS (pH 7.4), treated with 100 U of RNase A for 20 min at 37 °C, and stained with 50 µg of propidium iodide/ml. DNA content was detected using a Becton Dickinson FACScan flow cytometer.
Author contributions. Experiments were conceived and designed by GL, ML, JJB and RRS, and performed by GL, XC and ML. The manuscript was drafted by ML and revised by all authors.
Competing interests. The authors declare that they have no competing interests as defined by the Nature Publishing Group, or other interests that might be perceived to influence the results and/or discussion reported in this article.
The authors thank Drs. C. Pearson and D. Monckton for their comments on this work. This work was supported by a grant from the WSU Boonshoft School of Medicine to GL and by a grant from the NIH (GM53819) to ML.
Hairpin induced trinucleotide repeat instability. The TNR is indicated by grey lines, flanking DNA by black lines. (a) Nascent strand hairpin formation results in overreplication of a segment of the TNR in one chromatid. A second round of replication of the hairpin strand fixes the expanded allelle in the genome. (b) Template strand hairpin formation results in underreplication of a segment of the TNR in one chromatid. A second round of replication of the non-hairpin strand fixes the contracted allelle in the genome. (Adapted from
DNA replication affects TNR instability. (a) Diagram of ectopic origin sites. Arrowheads, PCR primer positions; bracket, DUE deletion (ΔDUE). (b) PCR analysis of (CTG)102•(CAG)102 cells cultured for 25 population doublings. Lane 1, (CTG)102 cells; lane 2, (CAG)102 cells; M, molecular weight marker. The progenitor (CTG)102•(CAG)102 band is indicated. (c) PCR analysis of (CTG)102•(CAG)102 cells cultured for 250 population doublings. Lane 1, (CTG)102 cells; lane 2, (CAG)102 cells. (d) PCR analysis of (CTG)12•(CAG)12 cells cultured for 25 or 250 population doublings. Lanes 1, 3, (CTG)12 cells; lanes 2, 4, (CAG)12 cells. The progenitor (CTG)12•(CAG)12 band is indicated. (e) PCR analysis of ΔDUE-(CTG)102•(CAG)102 cells cultured for 25 or 250 population doublings. Lanes 1, 3, ΔDUE-(CTG)102 cells; lanes 2, 4, ΔDUE-(CAG)102 cells.
ZFN cleave specifically in vitro. (a) Binding of a ZFNCTG and ZFNCAG heterodimer capable of cleaving heteroduplex DNA. Fok ICD, Fok I catalytic domain; ZFPGCT, GCT recognition zinc finger protein; ZFAGC, AGC recognition zinc finger protein. (b) Predicted modes of ZFNCTG monomer binding to heteroduplex DNA (upper) or homodimeric ZFNCTG capable of cleaving (CTG)n hairpin DNA (lower). (c) The linear (CTG)102•(CAG)102 PCR product was gel purified and reamplified. Time course of cleavage of the reamplified (CTG)102•(CAG)102 PCR products with ZFNCTG (10% of immunoprecipitate, lanes 1–3) or ZFNCAG (10% of immunoprecipitate, lanes 4–6). (d) Time course of cleavage of the reamplified (CTG)102•(CAG)102 PCR products with a mixture of ZFNCTG and ZFNCAG (5% of each immunoprecipitate).
(CTG)102•(CAG)102 TNRs form hairpins in vivo. (CTG)102•(CAG)102 cells were cultured for 25 population doublings. (a) spPCR of DNA from (CTG)102 cells or (CAG)102 cells transfected, respectively, with empty vector (lanes 1–4, 9–12) or ZFNCTG expression plasmid (lanes 5–8, 13–16). (b) spPCR of DNA from (CTG)102 cells (lanes 1–5) or (CAG)102 cells (lanes 6–9) transfected with ZFNCAG expression plasmid. (c) spPCR of DNA from (CTG)102 cells or (CAG)102 cells transfected, respectively, with empty vector (lanes 1–4, 5–8) or a 0.5:0.5 mixture of ZFNCTG and ZFNCAG expression plasmids (lanes 9–12, 13–16). (d) spPCR of DNA from (CTG)102 cells or (CAG)102 cells transfected with ZFPCTG (lanes 1–8) or ZFPCAG (lanes 9–16) expression plasmids. Lanes 1–4 and 5–8 were merged from nonadjacent lanes of the same gel, as were lanes 9–12 and lanes 13–16. (See
(CTG)102•(CAG)102 hairpin formation is suppressed by serum starvation. (CTG)102•(CAG)102 cells were grown for 25 population doublings and transferred to medium containing 0.5% serum for 48 hr. (a) spPCR of DNA from (CTG)102 cells (lanes 1–8) or (CAG)102 cells (lanes 9–16) transfected with the ZFNCTG expression plasmid. (b) spPCR of DNA from (CTG)102 cells (lanes 1–8) or (CAG)102 cells (lanes 9–16) transfected with the ZFNCAG expression plasmid. (c) spPCR of DNA from (CTG)102 cells (lanes 1–8) or (CAG)102 cells (lanes 9–16) transfected with the ZFNCAG and ZFNCAG expression plasmids.
(CTG)12•(CAG)12 TNRs are stable in vivo. (CTG)12 or (CAG)12 cells were cultured for 25 population doublings. (a) PCR of DNA from (CTG)12 (lane 1, 3) or (CAG)12 cells (lane 2, 4) treated with aphidicolin, or mock treated, as indicated. (b) PCR of DNA from (CTG)12 (lane 1, 3, 5, 7) or (CAG)12 cells (lane 2, 4, 6, 8) treated with emetine, Fen1 siRNA, or mock treated, as indicated. (c) spPCR of DNA from untreated (CTG)12 (lane 1–8) or (CAG)12 cells (lane 9–16). (d) spPCR of DNA from (CTG)12 or (CAG)12 cells expressing ZFNCTG (lanes 1–8) or ZFNCAG (lanes 9–16), as indicated. (e) spPCR of DNA from (CTG)12 (Lanes 1–6) or (CAG)12 cells (lanes 7–12) expressing a 0.5:0.5 mixture of ZFNCTG and ZFNCAG.